TPO and autoimmune thyroid disease: The T1gNET development was associated with anti-thyroperoxidase antibodies, highlighting the well-known autoimmune comorbidity in CAG patients, such as autoimmune thyroiditis [2], defining a specific syndrome known as thyrogastric syndrome [42].